AKT1 and chronic myelogenous leukemia, BCR-ABL1 positive: MiR-3142-induced adriamycin resistance occurs through the targeting of PTEN, which leads to downregulation of the PTEN protein and activation of the PI3K/Akt pathway in chronic myeloid leukemia (CML) cells [31].